Use of ibritumomab tiuxetan anti-CD20 radioimmunotherapy in a non-Hodgkin's lymphoma patient previously treated with a yttrium-90-labeled anti-CD22 monoclonal antibody. (Record no. 12619601)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 02011 a2200553 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250514072645.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 200311s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1526-9655 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.3816/clm.2003.n.015 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Tsai, Donald E |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20031118 |
245 00 - TITLE STATEMENT | |
Title | Use of ibritumomab tiuxetan anti-CD20 radioimmunotherapy in a non-Hodgkin's lymphoma patient previously treated with a yttrium-90-labeled anti-CD22 monoclonal antibody. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Clinical lymphoma |
Date of publication, distribution, etc. | Jun 2003 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 56-9 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antibodies, Monoclonal |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antibodies, Monoclonal, Humanized |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antigens, CD |
General subdivision | immunology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antigens, CD20 |
General subdivision | immunology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antigens, Differentiation, B-Lymphocyte |
General subdivision | immunology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | B-Lymphocytes |
General subdivision | immunology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cell Adhesion Molecules |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Disease Progression |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Lectins |
General subdivision | immunology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Lymphoma, Non-Hodgkin |
General subdivision | immunology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Male |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Middle Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Neoplasm Recurrence, Local |
General subdivision | immunology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Radioimmunotherapy |
General subdivision | methods |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Radiopharmaceuticals |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Sialic Acid Binding Ig-like Lectin 2 |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Treatment Outcome |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Yttrium Radioisotopes |
General subdivision | therapeutic use |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Maillard, Ivan |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Schuster, Stephen J |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Nasta, Sunita D |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Porter, David L |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Klumpp, Thomas R |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Goldenberg, David M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Luger, Selina M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Alavi, Abass |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Sharkey, Robert M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Hartzell, Kenneth B |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Stadtmauer, Edward A |
773 0# - HOST ITEM ENTRY | |
Title | Clinical lymphoma |
Related parts | vol. 4 |
-- | no. 1 |
-- | p. 56-9 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.3816/clm.2003.n.015">https://doi.org/10.3816/clm.2003.n.015</a> |
Public note | Available from publisher's website |
No items available.